Reuters logo
BRIEF-AMAG Pharma announces proposed offering of $250 mln of convertible senior notes due 2022
May 3, 2017 / 9:30 PM / 5 months ago

BRIEF-AMAG Pharma announces proposed offering of $250 mln of convertible senior notes due 2022

May 3 (Reuters) - AMAG Pharmaceuticals Inc

* AMAG Pharmaceuticals Inc announces proposed offering of $250 million of convertible senior notes due 2022

* AMAG Pharmaceuticals Inc says notes will pay interest semiannually and will mature on june 1, 2022

* AMAG Pharmaceuticals Inc -intends to use net proceeds from offering of notes together with cash on hand to repay approximately $320.8 million of borrowings

* AMAG Pharmaceuticals Inc says may enter into privately negotiated transactions with certain holders of its existing 2.50% convertible senior notes due 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below